MeiraGTx Holdings (MGTX) Profit After Tax (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Profit After Tax of $17.7 million for Q4 2025, up 135.86% on a QoQ basis from -$49.3 million in Q3 2025, and up 144.88% year-over-year from $7.2 million in Q4 2024.
MeiraGTx Holdings (MGTX) Profit After Tax (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Profit After Tax history runs 9 years deep, the most recent figure standing at $17.7 million for Q4 2025.
- Quarterly Profit After Tax rose 144.88% year-over-year to $17.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$110.4 million (up 25.3% YoY) and the FY2025 annual result came in at -$114.2 million, up 22.73% from the prior year.
- Profit After Tax was $17.7 million for Q4 2025 at MeiraGTx Holdings, up from -$49.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $20.2 million in Q4 2023 and bottomed at -$49.3 million in Q3 2025.
- A 5-year average of -$27.7 million and a median of -$30.7 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 357.78% — and 2025, when it surged 144.88%.
- MeiraGTx Holdings' Profit After Tax stood at -$9.9 million in 2021, then plunged by 357.78% to -$45.4 million in 2022, then jumped by 144.55% to $20.2 million in 2023, then plunged by 294.9% to -$39.4 million in 2024, then jumped by 144.88% to $17.7 million in 2025.
- Business Quant data shows MGTX's Profit After Tax at $17.7 million in Q4 2025, -$49.3 million in Q3 2025, and -$38.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 17.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.68 Mn |
| Sep 30, 2025 | -49.30 Mn |
| Jun 30, 2025 | -38.80 Mn |
| Mar 31, 2025 | -39.98 Mn |
| Dec 31, 2024 | -39.40 Mn |
| Sep 30, 2024 | -39.33 Mn |
| Jun 30, 2024 | -48.62 Mn |
| Mar 31, 2024 | -20.44 Mn |
| Dec 31, 2023 | 20.22 Mn |
| Sep 30, 2023 | -38.29 Mn |
| Jun 30, 2023 | -29.58 Mn |
| Mar 31, 2023 | -30.36 Mn |
| Dec 31, 2022 | -45.38 Mn |
| Sep 30, 2022 | -28.51 Mn |
| Jun 30, 2022 | -33.97 Mn |
| Mar 31, 2022 | -31.05 Mn |
| Dec 31, 2021 | -9.91 Mn |
| Sep 30, 2021 | -25.95 Mn |
| Jun 30, 2021 | -20.09 Mn |
| Mar 31, 2021 | -23.62 Mn |